相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for high-Risk Acute Leukemia: Successful Engraftment and Mild GVHD
Mei Guo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation
Olle Ringden et al.
BLOOD (2009)
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study
M. Schleuning et al.
BONE MARROW TRANSPLANTATION (2009)
Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis
Y. Lai et al.
BONE MARROW TRANSPLANTATION (2009)
HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia
Mukta Arora et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007
J. M. Goldman
BONE MARROW TRANSPLANTATION (2008)
Current and emerging treatment options in chronic myeloid leukemia
Elias Jabbour et al.
CANCER (2007)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
BN Savani et al.
BONE MARROW TRANSPLANTATION (2005)
Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group
N Basara et al.
BONE MARROW TRANSPLANTATION (2005)
A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors
M Robin et al.
LEUKEMIA (2005)
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
KS Baker et al.
BLOOD (2004)
Extended follow-up of patients treated with imatinib mesylate (Gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation:: Durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease
DJ Deangelo et al.
CLINICAL CANCER RESEARCH (2004)
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
JP Radich et al.
BLOOD (2003)
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation
N Fehse et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2003)
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
C Guglielmi et al.
BLOOD (2002)
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation
DJ Weisdorf et al.
BLOOD (2002)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
